KRAS and gastric cancer: Notably, the Anxa10-CreERT2 mice with Cdh1 and Smad4 deletion, simultaneously with Kras activation, developed poorly differentiated tumors with diffuse-type gastric cancer morphology, which was histologically characterized by signet ring cells.